Abelcet Radiotagging Protocol: Inhaled Lipid Complex Abelcet® in Lung Transplant Recipients
This study has been terminated.
(study completed)
Sponsor:
University of Pittsburgh
Collaborator:
Enzon Pharmaceuticals, Inc.
Information provided by:
University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT00235651
First received: October 6, 2005
Last updated: December 16, 2008
Last verified: December 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | April 2006 |
| Estimated Primary Completion Date: | No date given |